Pleased to be sharing our latest data with the DMD community at MDA 2026 highlighting RIPPLE™ as an efficient, scalable, nonviral platform for full-length dystrophin delivery in DMD. Get more details: www.sonothera.com
#MDA #SonoThera #DMD #neuromusculardiseases #nonviral #ultrasound #genetherapy

Pleased to be sharing our latest data with the DMD community at MDA 2026 highlighting RIPPLE™ as an efficient, scalable, nonviral platform for full-length dystrophin delivery in DMD. Get more details: www.sonothera.com
#neuromusculardiseases #MDA #genetherapy #nonviral #ultrasound #DMD #SonoThera

Returning to ASH, focused on Hemophilia A. Our new results demonstrate nonviral, targeted payload delivery to liver with our RIPPLE™ ultrasound mediated delivery technology resulting in up to 65% of normal Factor VIII protein expression in NHP models: sonothera.com/press-releas...
#ASH25 #SonoThera

New data at ASN Kidney Week 2025 demonstrating the potential of ultrasound-mediated delivery. Learn about our latest results in the treatment of X-Linked Alport Syndrome, delivering full-length gene expression: sonothera.com/press-releas...

#KidneyWk #SonoThera #XLAS #ultrasound #geneticmedicine

Presenting new data @MDAorg Clinical & Scientific Conference highlighting potential of genetic medicine using targeted, ultrasound-mediated delivery in treating DMD. Learn more: sonothera.com/press-releases #geneticmedicine #ultrasound #ultrasoundmediated #SonoThera #MDAconference #MuscularDystrophy